<DOC>
	<DOCNO>NCT01530763</DOCNO>
	<brief_summary>This study safety effectiveness ceftaroline fosamil child Community Acquired Bacterial Pneumonia receive antibiotic therapy hospital .</brief_summary>
	<brief_title>Safety Efficacy Study Ceftaroline Versus Comparator Pediatric Subjects With Community Acquired Bacterial Pneumonia ( CABP )</brief_title>
	<detailed_description>To evaluate safety , effectiveness , pharmacokinetics tolerance ceftaroline fosamil child initially hospitalize Community Acquired Bacterial Pneumonia ( CABP )</detailed_description>
	<mesh_term>Pneumonia</mesh_term>
	<mesh_term>Pneumonia , Bacterial</mesh_term>
	<mesh_term>Ceftriaxone</mesh_term>
	<mesh_term>Clavulanic Acid</mesh_term>
	<mesh_term>Clavulanic Acids</mesh_term>
	<mesh_term>Cephalosporins</mesh_term>
	<mesh_term>Amoxicillin-Potassium Clavulanate Combination</mesh_term>
	<mesh_term>Amoxicillin</mesh_term>
	<criteria>Male female , 2 month &lt; 18 year old . Presence CABP require hospitalization IV antibacterial therapy Documented history hypersensitivity allergic reaction Î²lactam antimicrobial . Confirmed suspect infection pathogen know resistant ceftriaxone . Confirmed suspect respiratory tract infection attribute source CABP pathogen . Noninfectious cause pulmonary infiltrates .</criteria>
	<gender>All</gender>
	<minimum_age>2 Months</minimum_age>
	<maximum_age>18 Years</maximum_age>
	<verification_date>January 2015</verification_date>
	<keyword>Infections</keyword>
	<keyword>Pediatrics</keyword>
	<keyword>Teflaro</keyword>
	<keyword>cephalosporin</keyword>
</DOC>